Search Results 371-380 of 17537 for Assay
... assays (which occurs in July 2018), in the midst of our study period. Participation eligibility. Participant eligibility includes age, gender, type and stage ...
... assay for the sensitive detection of CXCL10 in plasma-derived sEV, and 3) characterization of plasma-derived sEV through assessment of concentration, size ...
Comparison of two interferon-gamma release assays (IGRAs) for diagnosis of pediatric tuberculosis.This is a collaboration with the Centers for Disease ...
... assay should be available - Part F only - Participants must have CPS ≥1 by local PD-L1 IHC assay to be eligible for enrollment. Participants must be able ...
... assays. Early detection of cancer. Multiple myeloma is preceded by two benign conditions called monoclonal gammopathy of undetermined significance and ...
The objective of this study is to leverage novel molecular assays to identify predictive and prognostic biomarkers for sarcoma. Participation eligibility.
... assay, or have at least one high-risk pathological feature. Parameters Associated with Adenoma Detection Rate in Colonoscopy Scottsdale/Phoenix, AZ. The ...
The Lymph2Cx test helps determine where the lymphoma started, assigning “cell-of-origin” groups using a 20-gene expression-based assay. It is the first test ...
Assays for troponin with sensitivity into the pg/ml range have now been introduced. A majority of patients greater than age 50 have ... Proton Therapy for ...
The EMERALD study aimed to develop and test a blood-based assay for ... Detection of esophageal cancer via assay of novel methylated DNA markers in plasma.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.